Examination Report |
1 | TM-1 | 25 Jun 2014 |
2 | Reply to Exam Report (MIS-R) | 04 May 2017 |
3 | Reply to Exam Report (MIS-R) | 08 May 2017 |
4 | Reply to Exam Report (MIS-R) | 08 May 2017 |
5 | Reply to Exam Report (MIS-R) | 08 May 2017 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 27 Mar 2018 |
7 | Journal Copy | 22 Jun 2018 |
8 | Certificate | 30 Aug 2018 |
9 | TM-R(RENEWAL OF TRADE MARK) | 24 Jun 2024 |
1 | Dispatching of Examination Report for : 2762100 | 2940503 | 1506424 | 28 Jan 2016 |
2 | Dispatching of Examination Report for : 2762100 | 2940452 | 1506424 | 28 Jan 2016 |
3 | Dispatching of Examination Report for : 2762100 | 2940472 | 1506424 | 28 Jan 2016 |
4 | Abandoned Order for Application No 2762100 | 3413038 | 1781434 | 31 Mar 2016 |
5 | Hearing Notice (Show Cause) | 5928829 | 2672898 | 20 Feb 2018 |
6 | Tribunal Accepted Notice for : 2762100 | 6169721 | 2760159 | 03 Apr 2018 |
7 | O3 NOTICE | 17972410 | 6730261 | 16 Apr 2024 |
8 | RENEWAL INTIMATION LETTER | 18402684 | 27 Jun 2024 |
As per IP India data the trademark was applied on 25 June 2014.
MACLEODS PHARMACEUTICALS applied for Ibrumac.
Listed class of trademark Ibrumac is 5.
Ibrumac is on the Registered stage of the trademark process.
Serial Number provided to trademark application is 2762100
Trademark application was filed by the following attorney agent:
Singh And Singh Law Firm Llp
The trademark is categorized as DEVICE.